Sichenzia Ross Ference LLP Acts as Principal Attorney Liaison for Zelda Therapeutics Ltd on OTCQX Listing

By Sichenzia Ross Ference LLP | September 15, 2018

Press Release – New York, NY – September 14, 2018 – Sichenzia Ross Ference LLP announced today that it has sponsored Zelda Therapeutics Ltd (OTCQX: “ZLDAF”), an Australian biotechnology company studying the use of medicinal cannabis to treat a variety of ailments, for the OTCQX.

Sichenzia Ross Ference is a qualified firm responsible for providing guidance on OTCQX requirements and recommending membership. The Sichenzia Ross Ference team was led by Partner Darrin Ocasio.

Posted in News, Press Releases and tagged biotech, srf llp